References
Gabert J, Beillard E, van der Velden VHJ et al (2003) Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer Program. Leukemia 17:2318–2357. https://doi.org/10.1038/sj.leu.2403135
Coltro G, Mangaonkar AA, Lasho TL et al (2020) Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients. Leukemia 34:1407–1421. https://doi.org/10.1038/s41375-019-0690-7
Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405. https://doi.org/10.1182/blood-2016-03-643544
Chelapareddy LR, Sen S (2018) Philadelphia translocation in MDS: a case report and a brief review of the literature looking at its prevalence, disease progression, and treatment options. Case Rep Hematol 2018:1–6. https://doi.org/10.1155/2018/5865321
Bacher U, Haferlach T, Alpermann T et al (2011) Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations: subclones with the t(9;22)/BCR-ABL1 rearrangement. Br J Haematol 152:713–720. https://doi.org/10.1111/j.1365-2141.2010.08472.x
Wakayama T, Maniwa Y, Ago H et al (2001) A variant form of myelodysplastic syndrome with Ph− minor-BCR/ABL transcript. Int J Hematol 74:58–63. https://doi.org/10.1007/BF02982550
Roumier C, Daudignon A, Soenen V et al (1999) p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? 84:6
Author information
Authors and Affiliations
Contributions
ON, MO, EF, and BP performed morphological assays. ON, MO, EF, HG, PR, and BP performed genetics assays. LG and CB provided clinical data. BP, CRL, and HG wrote the manuscript which was approved by all authors.
Corresponding author
Ethics declarations
Ethics approval
The study was conducted according to the Declaration of Helsinki and was approved by the Human Research Committee of Lille and the internal review board of the Lille University Hospital Tumor Bank (certification NF 96900-2014/65453-1).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Podvin, B., Guermouche, H., Roynard, P. et al. Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia. Ann Hematol 101, 2093–2095 (2022). https://doi.org/10.1007/s00277-022-04861-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-04861-4